Additional file 3 of Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results

Authors :: Osuga, Yutaka
Seki, Yoshifumi
Tanimoto, Masataka
Kusumoto, Takeru
Kudou, Kentarou
Terakawa, Naoki
Publication Year :: 2021
Publisher :: figshare, 2021.
Abstract: Additional file 3. Change from baseline in mean of B&B score for pelvic pain, dysmenorrhea, and dyspareunia by visit.

Full Text Access

Tools